Skip to main content

Cuprina Holdings

corporate_fare Company Profile

Cuprina Holdings

CUPR·NASDAQ·Industrial Applications And Services·CIK 0001995704

Cuprina Holdings is a Singapore-based biomedical and biotechnology company focused on developing and commercializing innovative products for chronic wound management and operating in the health and beauty sector. The company utilizes its biomedical research expertise to identify and use naturally derived materials to develop medical device wound care products that meet international standards. As of December 31, 2025, Cuprina Holdings manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name. These MEDIFLY products are used as a biological debridement tool for chronic wounds in a procedure known as Maggot Debridement Therapy (MDT). In addition to the commercialized MEDIFLY products, Cuprina Holdings has three lines of chronic wound care products in its pipeline. These include Collagen dressings, such as sponges, particles, and hydrogels, which utilize bullfrog collagen derived from American bullfrog abattoir waste streams. The pipeline also includes Iodine-based topical antiseptic products for wound care and products utilizing medical leeches for wound treatment. Development of these pipeline products is expected to occur over 2026 and 2027, with commercial availability subject to regulatory approval. Cuprina Holdings focuses on developing functionally specific chronic wound care products designed to address the major stages of the wound healing process, from chronic to closure.

Cuprina Holdings (NASDAQ:CUPR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for CUPR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-02, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for CUPR spans 6-K, 424B4, F-1/A, F-1.

Recent high-impact activity:

  • Cuprina to Acquire Seven-Clinic Singapore Healthcare Group for S$4.0M
  • Cuprina to Acquire Seven-Clinic Singapore Healthcare Group for S$4M
  • Cuprina Holdings Closes Over-Allotment Option, Raising Total Offering Proceeds to $5.7M
  • Cuprina Seeks 100x Increase in Authorized Shares to 1.25B
  • Cuprina Closes $4.97M Public Offering at $1.15/Share; Underwriter Gets 172,900 Warrants

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
S$49.89K SGD
Net Income
-S$4.67M SGD
Diluted EPS
-S$22.83 SGD
Op. Cash Flow
-S$9.13M SGD
Free Cash Flow
-S$9.19M SGD
Gross Profit
-S$645 SGD
Operating Income
-S$4.83M SGD
Cash & Equivalents
S$3.12M SGD
Total Debt
S$164.93K SGD
Debt / Equity
0.03×
Net Margin
-93.67×
Shares Outstanding
20.47M sh
Source: 20-F · filed 2026-07-01 · accession 0001493152-26-031415

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 2,739 shares in CUPR as of the October 30, 2026 settlement, a 81.0% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 49.9% of CUPR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,739 shares as of October 30, 2026
Change vs prior period▼ 81.0%
Days to cover1.00 at avg daily volume of 128,792
Daily short volume (FINRA facilities)49.9% of 13,280 shares on November 20, 2026
5-day average short volume50.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for CUPR, detected from its recent SEC filings · based on capital-structure filings through 2026-09-16.

1 recent capital raise1 shelf registrationreverse split

Offering Priced at Deep Discount · Massive Dilution to Existing Holders

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

CUPR files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with C →
$1.41
52-week range · as of 2026-10-02 $1.41 – $14.8
Market cap
$8.31M
Volume
38.6K (0.4× avg)
3-mo avg 90.2K
Live data · 2026-11-22 02:30 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CUPR - Latest Insights

CUPR
Oct 02, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.62
Real-time Price: $1.41 info
Change: -$1.21 (-46%) info
Market Cap: $8.307M info
CUPR
Oct 02, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.62
Real-time Price: $1.41 info
Change: -$1.21 (-46%) info
Market Cap: $8.307M info
CUPR
Sep 29, 2026, 4:00 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.01
Real-time Price: $1.41 info
Change: -$0.600 (-30%) info
Market Cap: $8.307M info
CUPR
Sep 18, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.69
Real-time Price: $1.41 info
Change: -$0.280 (-17%) info
Market Cap: $8.307M info
CUPR
Sep 17, 2026, 9:55 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.68
Real-time Price: $1.41 info
Change: -$0.270 (-16%) info
Market Cap: $8.307M info
CUPR
Sep 16, 2026, 2:30 PM EDT
Filing Type: 424B4
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $1.41 info
Change: -$0.340 (-19%) info
Market Cap: $8.307M info
CUPR
Sep 16, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.63
Real-time Price: $1.41 info
Change: -$0.220 (-13%) info
Market Cap: $8.307M info
CUPR
Sep 11, 2026, 11:14 AM EDT
Filing Type: F-1/A
Importance Score:
9
Price at Filing: $3.20
Real-time Price: $1.41 info
Change: -$1.79 (-56%) info
Market Cap: $8.307M info
CUPR
Jul 07, 2026, 1:14 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $5.48
Real-time Price: $1.41 info
Change: -$4.07 (-74%) info
Market Cap: $8.307M info
CUPR
Jul 07, 2026, 12:43 PM EDT
Filing Type: F-1
Importance Score:
8
Price at Filing: $5.47
Real-time Price: $1.41 info
Change: -$4.06 (-74%) info
Market Cap: $8.307M info
CUPR
Jul 01, 2026, 6:20 AM EDT
Filing Type: 20-F/A
Importance Score:
7
Price at Filing: $5.82
Real-time Price: $1.41 info
Change: -$4.41 (-76%) info
Market Cap: $8.307M info
CUPR
Jun 24, 2026, 7:40 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $5.37
Real-time Price: $1.41 info
Change: -$3.96 (-74%) info
Market Cap: $8.307M info
CUPR
Jun 15, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $5.75
Real-time Price: $1.41 info
Change: -$4.34 (-75%) info
Market Cap: $8.307M info
CUPR
Jun 15, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $6.83
Real-time Price: $1.41 info
Change: -$5.42 (-79%) info
Market Cap: $8.307M info
CUPR
Jun 12, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.44
Real-time Price: $1.41 info
Change: -$1.03 (-42%) info
Market Cap: $8.307M info
CUPR
Jun 12, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $2.87
Real-time Price: $1.41 info
Change: -$1.46 (-51%) info
Market Cap: $8.307M info
CUPR
May 29, 2026, 12:55 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $2.47
Real-time Price: $1.41 info
Change: -$1.06 (-43%) info
Market Cap: $8.307M info
CUPR
May 14, 2026, 10:03 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.260
Real-time Price: $1.41 info
Change: Reverse Stock Split info
Market Cap: $8.307M info
CUPR
Apr 27, 2026, 9:13 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.3031
Real-time Price: $1.41 info
Change: Reverse Stock Split info
Market Cap: $8.307M info
CUPR
Apr 21, 2026, 9:20 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.3558
Real-time Price: $1.41 info
Change: Reverse Stock Split info
Market Cap: $8.307M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets